List of works - Jan N Basile

A lower blood pressure goal in patients without diabetes lessens the occurrence of left ventricular hypertrophy

scientific article published on 01 February 2010

AHA scientific statement: new blood pressure targets for high-risk and established coronary artery disease patients

scientific article published on 01 August 2007

Advance trial supports current recommendations for blood pressure goals and not the use of any specific combination of antihypertensive agents in patients with type 2 diabetes

scientific article published on 01 January 2008

African American patients with hypertensive chronic kidney disease receive no benefit on kidney disease progression from the currently recommended blood pressure goal of <130/80 mm Hg unless there is significant proteinuria at baseline: long-term fo

scientific article published on December 17, 2010

Aliskerin, an oral renin inhibitor, in combination with a thiazide diuretic, ace inhibitor, or angiotensin receptor antagonist reduces 24-hour blood pressure and suppresses plasma renin activity

scientific article published on 01 April 2007

Ambulatory blood pressure monitoring to diagnose hypertension--an idea whose time has come

scientific article published on 09 November 2015

Analysis of recent papers in hypertension

scientific article published on 01 January 2006

Analysis of recent papers in hypertension

scientific article published on 01 February 2006

Analysis of recent papers in hypertension

scientific article published on 01 December 2008

Analysis of recent papers in hypertension Jan Basile , MD , Senior Editor

scientific article published on 01 October 2008

Analysis of recent papers in hypertension treatment of hypertension in the setting of acute intracerebral hemorrhage: still no clear answer on the best BP level to intervene or what BP goal to achieve

scientific article published on 11 December 2013

Analysis of recent papers in hypertension: Treatment of obstructive sleep apnea with continuous positive airway pressure appears to decrease the incidence of incident hypertension

scientific article published on 14 December 2012

Analysis of recent papers in hypertension: a simple office-based tool to predict the development of hypertension

scientific article published on 01 May 2008

Analysis of recent papers in hypertension: differences in central aortic blood pressure explain outcome differences in ASCOT: the CAFE substudy; and rimonabant improves multiple cardiometabolic parameters in overweight and obese individuals

scientific article published on 01 May 2006

Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease

scientific article

Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questionable

scientific article published on 01 June 2010

Blood pressure control rates in Spain are further improved using daytime ambulatory measurements than when using conventional office based measurement

scientific article published on 01 April 2007

Blood pressure reduction appears more important than specific antihypertensive agent used to improve diastolic function

scientific article published on 01 September 2007

Cholesterol ester transfer protein inhibition with torcetrapib leads to an increase in cardiovascular events: an effect that is unlikely to be the result of increases in blood pressure alone

scientific article published in February 2008

Chronotherapy in patients with chronic kidney disease to reduce nighttime blood pressure--not ready for prime time

scientific article published on 01 March 2008

Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone

scientific article published on 20 August 2010

Comparative effectiveness of medical therapy compared with initial percutaneous intervention in the treatment of atherosclerotic renal artery stenosis

scientific article published on 01 March 2007

Correction of thiazide-induced hypokalemia prevents hyperglycemia and incident diabetes mellitus

scientific article published on 01 October 2006

Defining the role of angiotensin receptor blocker therapy in Japanese persons with underlying vascular disease: the Jikei Heart Study

scientific article published on 01 July 2007

Determining the Relative Antihypertensive Potency and Relative Cardiovascular Risk Reduction Associated With Different Thiazide and Thiazide‐Type Diuretics ⬇️

scientific article published on February 27, 2013

Development of new-onset diabetes mellitus is associated with an increased risk for cardiac morbidity: the VALUE Trial

scientific article published on 01 November 2007

Diagnosis and management of renovascular disease and renovascular hypertension

scientific article published on May 2007

Effects of a calcium channel blocker and a statin-based treatment regimen in the Anglo-Scandinavian Cardiac Outcomes Trial

scientific article published on 01 February 2007

Exposure to Air Pollution Increases the Incidence of Hypertension and Diabetes in Black Women Living in Los Angeles ⬇️

scientific article published on August 28, 2012

Heart failure in people younger than 50 years is more common in black than white Americans and is closely associated with poorly treated and controlled hypertension: the CARDIA study

scientific article published on 01 July 2009

High adherence to antihypertensive therapy is rare but when present is associated with a decreased risk of cardiovascular events

scientific article published on 01 March 2010

Hypertension patients with multiple comorbidities are more likely to have their BP controlled within the VA healthcare system: unfounded concerns about pay-for-performance

scientific article published on 01 October 2009

Hypertension prevalence increases and hypertension control rates improve in the United States: 2003-2004

scientific article published on 01 February 2007

Identifying and managing factors that interfere with or worsen blood pressure control

scientific article published on March 2010

In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk patients with impaired glucose tolerance

scientific article published on 20 August 2010

Intensive blood pressure control in children slows progression of chronic kidney disease

scientific article published on 01 July 2010

Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke

scientific article published on 01 July 2010

Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more importan

scientific article published on 01 December 2009

Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message

scientific article published on 24 August 2010

New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United States

scientific article published on 26 September 2011

Number of visits at goal blood pressure is associated with improved cardiovascular outcomes--a post hoc analysis of the INVEST trial

scientific article published on 01 October 2007

Patient Self‐management Improves Blood Pressure Control ⬇️

scientific article published on December 13, 2010

Percutaneous revascularization of the renal arteries offers no evidence of clinical benefit in patients with atherosclerotic renal artery stenosis--the ASTRAL trial

scientific article published on 01 April 2010

Primary hyperaldosteronism in patients with resistant hypertension may be less prevalent than previously reported: evidence against an epidemic

scientific article published on 01 August 2008

Prior incarceration is associated with an increased risk for developing hypertension

scientific article published on 01 August 2009

Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends ⬇️

scientific article published on October 21, 2010

Review of recent literature in hypertension: updated clinical practice guidelines for chronic kidney disease now include albuminuria in the classification system

scientific article published on 30 September 2013

Review of recent literature: Existing kidney disease classification guideline needs to incorporate degree of proteinuria with estimated glomerular filtration rate to more accurately predict cardiovascular and renal risk

scientific article published on August 2010

Self measurement of blood pressure at home should complement rather than replace office blood pressure management

scientific article published on 01 April 2008

Spironolactone found effective for patients with resistant hypertension in ASCTT-BPLA

scientific article published on 01 July 2007

Spironolactone is More Effective Than Eplerenone at Lowering Blood Pressure in Patients With Primary Aldosteronism ⬇️

scientific article published on July 14, 2011

The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board

Thresholds for diastolic blood pressure reduction in older patients with isolated systolic hypertension appear to be different depending on the presence or absence of underlying coronary heart disease

scientific article published on 01 December 2007

Treating hypertension in the oldest of the old reduces total mortality: results of the Hypertension in the Very Elderly Trial (HYVET)

scientific article published on 01 June 2008

Treating the Black Hypertensive in 2010: Achieve Lower Targets While Awaiting More Definitive Evidence ⬇️

scientific article published on December 13, 2010

UK Guidelines Call for Routine 24-Hour Ambulatory Blood Pressure Monitoring in All Patients to Make the Diagnosis of Hypertension-Not Ready for Prime Time in the United States ⬇️

scientific article published on 07 November 2011

What Should be the Target Blood Pressure in Patients With Chronic Kidney Disease? Data From the Kidney Early Evaluation Program ⬇️

scientific article published on April 26, 2012

List of works by Jan N Basile

A lower blood pressure goal in patients without diabetes lessens the occurrence of left ventricular hypertrophy

AHA scientific statement: new blood pressure targets for high-risk and established coronary artery disease patients

Advance trial supports current recommendations for blood pressure goals and not the use of any specific combination of antihypertensive agents in patients with type 2 diabetes

African American patients with hypertensive chronic kidney disease receive no benefit on kidney disease progression from the currently recommended blood pressure goal of <130/80 mm Hg unless there is significant proteinuria at baseline: long-term fo

Aliskerin, an oral renin inhibitor, in combination with a thiazide diuretic, ace inhibitor, or angiotensin receptor antagonist reduces 24-hour blood pressure and suppresses plasma renin activity

Ambulatory blood pressure monitoring to diagnose hypertension--an idea whose time has come

Analysis of recent papers in hypertension

Analysis of recent papers in hypertension

Analysis of recent papers in hypertension

Analysis of recent papers in hypertension Jan Basile , MD , Senior Editor

Analysis of recent papers in hypertension treatment of hypertension in the setting of acute intracerebral hemorrhage: still no clear answer on the best BP level to intervene or what BP goal to achieve

Analysis of recent papers in hypertension: Treatment of obstructive sleep apnea with continuous positive airway pressure appears to decrease the incidence of incident hypertension

Analysis of recent papers in hypertension: a simple office-based tool to predict the development of hypertension

Analysis of recent papers in hypertension: differences in central aortic blood pressure explain outcome differences in ASCOT: the CAFE substudy; and rimonabant improves multiple cardiometabolic parameters in overweight and obese individuals

Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease

Angiotensin receptor blocker use may decrease the incidence and progression of Alzheimer's disease and dementia in older men but the strength of the evidence is questionable

Blood pressure control rates in Spain are further improved using daytime ambulatory measurements than when using conventional office based measurement

Blood pressure reduction appears more important than specific antihypertensive agent used to improve diastolic function

Cholesterol ester transfer protein inhibition with torcetrapib leads to an increase in cardiovascular events: an effect that is unlikely to be the result of increases in blood pressure alone

Chronotherapy in patients with chronic kidney disease to reduce nighttime blood pressure--not ready for prime time

Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone

Comparative effectiveness of medical therapy compared with initial percutaneous intervention in the treatment of atherosclerotic renal artery stenosis

Correction of thiazide-induced hypokalemia prevents hyperglycemia and incident diabetes mellitus

Defining the role of angiotensin receptor blocker therapy in Japanese persons with underlying vascular disease: the Jikei Heart Study

Determining the Relative Antihypertensive Potency and Relative Cardiovascular Risk Reduction Associated With Different Thiazide and Thiazide‐Type Diuretics ⬇️

Development of new-onset diabetes mellitus is associated with an increased risk for cardiac morbidity: the VALUE Trial

Diagnosis and management of renovascular disease and renovascular hypertension

Effects of a calcium channel blocker and a statin-based treatment regimen in the Anglo-Scandinavian Cardiac Outcomes Trial

Exposure to Air Pollution Increases the Incidence of Hypertension and Diabetes in Black Women Living in Los Angeles ⬇️

Heart failure in people younger than 50 years is more common in black than white Americans and is closely associated with poorly treated and controlled hypertension: the CARDIA study

High adherence to antihypertensive therapy is rare but when present is associated with a decreased risk of cardiovascular events

Hypertension patients with multiple comorbidities are more likely to have their BP controlled within the VA healthcare system: unfounded concerns about pay-for-performance

Hypertension prevalence increases and hypertension control rates improve in the United States: 2003-2004

Identifying and managing factors that interfere with or worsen blood pressure control

In navigator, the angiotensin receptor blocker valsartin modestly reduced the progression to type 2 diabetes but had no effect on cardiovascular events in higher-risk patients with impaired glucose tolerance

Intensive blood pressure control in children slows progression of chronic kidney disease

Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke

Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more importan

Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message

New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United States

Number of visits at goal blood pressure is associated with improved cardiovascular outcomes--a post hoc analysis of the INVEST trial

Patient Self‐management Improves Blood Pressure Control ⬇️

Percutaneous revascularization of the renal arteries offers no evidence of clinical benefit in patients with atherosclerotic renal artery stenosis--the ASTRAL trial

Primary hyperaldosteronism in patients with resistant hypertension may be less prevalent than previously reported: evidence against an epidemic

Prior incarceration is associated with an increased risk for developing hypertension

Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends ⬇️

Review of recent literature in hypertension: updated clinical practice guidelines for chronic kidney disease now include albuminuria in the classification system

Review of recent literature: Existing kidney disease classification guideline needs to incorporate degree of proteinuria with estimated glomerular filtration rate to more accurately predict cardiovascular and renal risk

Self measurement of blood pressure at home should complement rather than replace office blood pressure management

Spironolactone found effective for patients with resistant hypertension in ASCTT-BPLA

Spironolactone is More Effective Than Eplerenone at Lowering Blood Pressure in Patients With Primary Aldosteronism ⬇️

The Rheos Pivotol trial evaluating baroreflex activation therapy fails to meet efficacy and safety end points in resistant hypertension: back to the drawing board

Thresholds for diastolic blood pressure reduction in older patients with isolated systolic hypertension appear to be different depending on the presence or absence of underlying coronary heart disease

Treating hypertension in the oldest of the old reduces total mortality: results of the Hypertension in the Very Elderly Trial (HYVET)

Treating the Black Hypertensive in 2010: Achieve Lower Targets While Awaiting More Definitive Evidence ⬇️

UK Guidelines Call for Routine 24-Hour Ambulatory Blood Pressure Monitoring in All Patients to Make the Diagnosis of Hypertension-Not Ready for Prime Time in the United States ⬇️

What Should be the Target Blood Pressure in Patients With Chronic Kidney Disease? Data From the Kidney Early Evaluation Program ⬇️